Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Tumor-Agnostic 1Lymphoid 1

Conditions

Constipation 2Pain 1Neoplasms 1Intestinal Obstruction 1Bronchiolitis Obliterans Syndrome 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Naloxone × Other × Clear all
NCT00020605 2018-12-13

Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain

National Cancer Institute (NCI)

Phase 3 Unknown
Other

Constipation, Intestinal Obstruction

NCT00513656 2018-10-23

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

Mundipharma Research GmbH & Co KG

Phase 2 Completed
230 enrolled
Other

Bronchiolitis Obliterans Syndrome, Constipation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡